Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 1;35(4):171-178.
doi: 10.1097/MOL.0000000000000936. Epub 2024 Jun 18.

Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis

Paul Durrington  1 , Handrean Soran  2
Affiliations
Review

Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis

Paul Durrington et al. Curr Opin Lipidol. .

Abstract

Purpose of review: To review the discoveries which led to the concept that serum paraoxonase 1 (PON1) is inversely related to atherosclerotic cardiovascular disease (ASCVD) incidence, how this association came to be regarded as causal and how such a role might have evolved.

Recent findings: Animal models suggest a causal link between PON1 present on HDL and atherosclerosis. Serum PON1 activity predicts ASCVD with a similar reliability to HDL cholesterol, but at the extremes of high and low HDL cholesterol, there is discordance with PON1 being potentially more accurate. The paraoxonase gene family has its origins in the earliest life forms. Its greatest hydrolytic activity is towards lactones and organophosphates, both of which can be generated in the natural environment. It is active towards a wide range of substrates and thus its conservation may have resulted from improved survival of species facing a variety of evolutionary challenges.

Summary: Protection against ASCVD is likely to be the consequence of some promiscuous activity of PON1, but nonetheless has the potential for exploitation to improve risk prediction and prevention of ASCVD.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Box 1
Box 1
no caption available
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Aldridge WN. Serum esterases. 2. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E 600) and its identity with the A-esterase of mammalian sera. Biochem J 1953; 53:117–124. - PMC - PubMed
    1. Durrington PN, Bashir B, Soran H. Paraoxonase 1 and atherosclerosis. Front Cardiovasc Med 2023; 10:1065967. - PMC - PubMed

    2. A review of the evidence that paraoxonase 1 is causally associated with ASCVD and of what is known about the mechanisms underlying this association.

    1. Furlong CE. Paraoxonases: an historical perspective. In: Mackness B, Mackness M, Aviram M, Paragh G, editors. The paraoxonases: their role in disease development and xenobiotic metabolism. Dordrecht, Netherlands: Springer Netherlands; 2008. pp. 3–31.
    1. Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004; 369:78–88. - PubMed
    1. Mackness MI, Hallam SD, Peard T, et al. . The separation of sheep and human serum ‘A’-esterase activity into the lipoprotein fraction by ultracentrifugation. Comp Biochem Physiol B 1985; 82:675–677. - PubMed